גל ההנפקות בתל אביב ב-2026: 5 שנים של שיאים
Tel Aviv’s IPO queue is real again, and Tambour is the clearest test case. The real question is who gets the cash, and whether the price leaves anything for investors.

Tel Aviv’s IPO machine is back in motion, but the smart money is not asking how many companies want to list. It is asking whether each offering is a real capital raise for growth or a polished exit for existing owners. Tambour, the 1936 paint maker now controlled by Singapore’s Kusko Group, is the cleanest anchor for that question, because its planned NIS 2.5 billion valuation and NIS 500 million raise force investors to look past the brand and into the structure.
Why 2026 feels different
The local market is entering the new year from a position of strength, not desperation. On April 15, the TA-35 touched 4,428.64, while the TA-125 hit an all-time high of 4,353.25 in April 2026, and that kind of backdrop makes fundraising easier for companies with a credible story. The message is simple: when indices are breaking records, management teams are far more willing to test the public market.
The 2025 pipeline already showed the shift. TASE counted 19 new companies that went public that year, up from 5 in 2024 and just 1 in 2023, after 13 in 2022. The market also absorbed nearly NIS 6 billion in new equity, and the average return for new entrants was above 18%, which is exactly why more boards started to dust off prospectuses.
What changed from the 2021 IPO wave
This cycle is not the 2021 story all over again. The older wave was packed with dream-driven listings, companies selling future potential before the business had earned the right to be public. The current batch is different: more mature, more revenue-heavy, and more asset-backed.
That matters because retail investors keep making the same mistake. They see a recognizable name, a hot tape, and a first-day buzz, then assume the IPO itself is the opportunity. In reality, the opportunity begins only after you ask whether the business is already good, or simply well packaged.
Tambour is the anchor deal because it tells you what a real listing looks like
Tambour is a useful test case precisely because it is not a startup trying to sell a vision. It is an old industrial company, founded in 1936, with an operating history that spans cycles, inflation, construction booms, and slowdowns. It has been held since 2014 by Kusko Group of Singapore, whose owners are businessmen from Kazakhstan, and now it is aiming to raise capital in Tel Aviv on a scale that will be hard for the market to ignore.
The plan is to sell shares at an after-money valuation of NIS 2.5 billion and raise NIS 500 million. The money is supposed to go into the company and support expansion in Israel and abroad, with Barak-Leumi Underwriting and IBI Underwriting leading the transaction. That structure is already telling investors something important: this is not just a liquidity event, it is also a test of how the market prices a mature industrial asset.
The first question: is the valuation in line with peers?
The headline number is meaningless unless it is compared with similar businesses. For a company like Tambour, the real test is not whether NIS 2.5 billion sounds big or small, but whether the price fits the revenue base, the margin profile, the leverage, and the growth runway relative to other listed paint, coatings, and building-products companies.
If a prospectus leans hard on brand recognition while avoiding a clean peer comparison, that is a warning sign. Investors should ask whether the multiple is justified by quality and growth, or whether the seller is simply taking advantage of a strong market window. A good IPO price gives the public room to breathe; a stretched one leaves all the upside with the seller.
The second question: does the business still grow and earn?
A company can be old, profitable, and still overpriced. It can also be growing without making enough money to deserve a public premium. The right listing sits in the middle, where revenue, margins, and capital discipline move together.
For Tambour, the relevant issue is whether the planned expansion in Israel and abroad can lift the business without bloating costs or diluting returns. If growth depends on aggressive spending while profitability stays flat, the story is thinner than it looks. If the company can expand and still defend margins, then the market has something real to underwrite.
The third question: where does the money actually go?
This is where many IPOs reveal their true purpose. If the bulk of the proceeds funds investment inside the company, new plants, new geographies, working capital, or technology upgrades, the public is buying into growth. If the proceeds mostly circulate back to shareholders who want to reduce exposure, the transaction becomes a dressed-up exit.
Tambour’s stated use of proceeds is expansion, which is the better version of the story. Still, investors should not stop at the broad wording. They should check whether the company is using new capital to create value, or merely to create the impression of momentum while old owners lighten up.
The fourth question: how much stock are insiders actually selling?
This is the part many first-time IPO buyers skip, and it is the part that often matters most. Heavy selling by existing shareholders is not automatically a deal breaker, but it changes the reading of the offer. When insiders cash out aggressively, the market should demand a better price, because the sellers know the business better than anyone else.
A clean offering usually has a meaningful primary raise, with fresh capital entering the company. The more the deal tilts toward secondary sales, the more the buyer has to ask why the people closest to the asset are eager to reduce their exposure now. In plain language, if the insiders are rushing for the door, you should know why the exit is so attractive.
The fifth question: what are the real risk factors?
Risk sections in a prospectus are not decorative. They tell you which part of the business can break when conditions change. For Tambour, that means input costs, construction cycles, demand in Israel and abroad, foreign exchange exposure, and the simple fact that mature industrial businesses can look stable right up until margins start compressing.
Investors who read only the growth paragraphs are usually the ones who get hurt. The risk section is where you find the true business model, because it shows what management fears, what can slow the company down, and what can make the promised valuation look expensive very quickly. If the risks feel generic, that is itself a risk.
Why this matters for Israeli investors now
The Tel Aviv market is not just offering more IPOs, it is offering more choice at a moment when local sentiment is strong. That is a good thing, but it also creates a trap: when the tape is hot, almost any listing can look like a winner on day one. The harder job is figuring out whether the public is being invited into a quality business at a fair price, or asked to finance someone else’s timing.
A NIS 500 million raise is large enough to matter, and a NIS 2.5 billion valuation is visible enough to set a benchmark for the next deal. If Tambour lands well, it will encourage more companies to come out of the queue and test the market. If it is priced too aggressively, it will still list, but it will remind investors that a busy IPO pipeline is not the same thing as a healthy one.
שאלות נפוצות
How do I tell if an IPO is a real opportunity?
Start with valuation, then check growth, profitability, use of proceeds, insider selling, and the risk section. If the price is rich, the growth is modest, and the money mostly goes to existing owners, the deal leans more toward exit than opportunity.
Does a first-day jump mean the IPO is good?
Not necessarily. A strong opening can reflect demand, scarcity, or market mood, but it does not prove the business was priced correctly. Long-term performance depends on fundamentals, not the first print.
Why is Tambour important beyond one company?
Because it shows what the current Tel Aviv IPO market is rewarding: older, revenue-generating businesses with real assets and a clear use for capital. That is the opposite of the fantasy-listing era, and it tells investors how to read the next wave.
Is the 2026 IPO market only for institutions?
No. Retail investors can participate, but they need to be more selective than ever. In a strong market, the easiest money is often made by the seller at the IPO price, not by the buyer on the first day.
יודעים משהו שפספסנו? יש לכם תיקון או מידע נוסף?
שלחו טיפ

